Cargando…
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma
Background/Aim: To evaluate the association between baseline [18F]FDG-PET/CT tumor burden parameters and disease progression rate after first-line target therapy or immunotherapy in advanced melanoma patients. Materials and Methods: Forty four melanoma patients, who underwent [18F]FDG-PET/CT before...
Autores principales: | Liberini, Virginia, Rubatto, Marco, Mimmo, Riccardo, Passera, Roberto, Ceci, Francesco, Fava, Paolo, Tonella, Luca, Polverari, Giulia, Lesca, Adriana, Bellò, Marilena, Arena, Vincenzo, Ribero, Simone, Quaglino, Pietro, Deandreis, Désirée |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584809/ https://www.ncbi.nlm.nih.gov/pubmed/34768517 http://dx.doi.org/10.3390/jcm10214994 |
Ejemplares similares
-
(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
por: Polverari, Giulia, et al.
Publicado: (2020) -
Treatment of Advanced Metastatic Melanoma
por: Quaglino, Pietro, et al.
Publicado: (2021) -
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience
por: Rubatto, Marco, et al.
Publicado: (2023) -
Impact of segmentation and discretization on radiomic features in (68)Ga-DOTA-TOC PET/CT images of neuroendocrine tumor
por: Liberini, Virginia, et al.
Publicado: (2021) -
Event-free survival after (68) Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
por: Ceci, Francesco, et al.
Publicado: (2022)